Triple immunofluorescence labeling of atherosclerotic plaque components in apoE/LDLR -/- mice

Folia Histochemica et Cytobiologica

Volumn 46, Issue 2, 2008, Pages 143-146

  Gajda, Mariusz ^a   Jawień, Jacek ^a   Mateuszuk, Łukasz ^a   Lis, Grzegorz J ^a   Radziszewski, Andrzej ^a   Chłlopicki, Stefan ^a   Litwin, Jan A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

ApoE LDLR double knockout mice; Atherosclerosis; CD3; CD68; Immunohistochemistry; Smooth muscle actin

Indexed keywords

ACETONE; APOLIPOPROTEIN E; CD3 ANTIBODY; CD68 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; SMOOTH MUSCLE ACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; KNOCKOUT MOUSE; MACROPHAGE; MILK; MOUSE; NONHUMAN; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; ANIMAL; AORTA; ATHEROSCLEROSIS; C57BL MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY;

MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL;

EID: 48449092953     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0021-8     Document Type: Article

References (12)

1. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A. 1994;91:4431-4435.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V. Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg. 2004;38:11-23.
4. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG. Inflammation and atherosclerosis. Eur J Vasc Endovasc Surg. 2006;31:386-393.
5. Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res. 2003;59:234-240.
6. Jawien J, Gajda M, Rudling M, et al. Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/ LDLR-double knockout mice. Eur J Clin Invest. 2006;36:141-146.
7. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003;112:1342-1350.
8. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest. 1998;102:910-918.
9. Richter T, Nahrig J, Komminoth P, Kowolik J, Werner M. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol. 999;52:461-463.
10. Cinar O, Semiz O, Can A. A microscopic survey on the efficiency of well-known routine chemical fixatives on cryosections. Acta Histochem. 2006;108:487-496.
11. Brouns I, Van Nassauw L, Van Genechten J, et al. Triple immunofluorescence staining with antibodies raised in the same species to study the complex innervation pattern of intrapulmonary chemoreceptors. J Histochem Cytochem. 2002;50:575-582.
12. Duhamel RC, Johnson DA. Use of nonfat dry milk to block nonspecific nuclear and membrane staining by avidin conjugates. J Histochem Cytochem. 1985;33:711-714.